Moleculin Biotech announces annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Moleculin Biotech announced its annual shareholder meeting scheduled for October 9, 2026, in Houston. Key agenda items include board elections, charter amendments such as eliminating supermajority voting requirements, and an advisory vote on executive compensation. Notably, the ballot proposes a reverse stock split with ratios ranging from 1-for-2 to 1-for-20 and seeks to expand the 2024 Equity Incentive Plan share pool significantly.
- Shareholders meet in Houston on Oct. 9, 2026 to vote on board elections and several charter changes. * Ballot includes authority for a reverse stock split at a ratio from 1-for-2 to 1-for-20. * Vote also seeks to expand the 2024 Equity Incentive Plan share pool to 4,141,894 shares from 280,010 shares. * Other items include eliminating supermajority voting requirements for charter amendments, executive pay advisory vote, auditor ratification, adjournment authority. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028835), on August 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here